Product Information
MECLIZINE 50 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $2.4499 per EA under NDC 16571066201. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the Meclizine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571066201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA010721On Market Since
1/15/2020
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 50 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4499 per EA |
|---|---|
| All-time high | $2.5546 (Jan 14, 2026) |
| All-time low | $2.1724 (Feb 19, 2025) |
| 52-week high | $2.5546 |
| 52-week low | $2.4369 |
| Median price | $2.4499 |
| Average price | $2.4191 |
| Largest weekly change | -6.1% (Nov 20, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Meclizine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MECLIZINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 50 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $2.4499 per EA (NDC 16571066201), effective Jun 24, 2026.
How has the price of MECLIZINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 50 MG TABLET has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MECLIZINE 50 MG TABLET?
Since Apr 17, 2024, the NADAC for MECLIZINE 50 MG TABLET has ranged from a low of $2.1724 (Feb 19, 2025) to a high of $2.5546 (Jan 14, 2026), with a median of $2.4499 per EA.
Are there cheaper alternatives to MECLIZINE 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MECLIZINE 50 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures MECLIZINE 50 MG TABLET?
MECLIZINE 50 MG TABLET (NDC 16571066201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification